Clarithromycin suppresses the periodontal bacteria-accelerated abdominal aortic aneurysms in mice

Journal of Periodontal Research

Volumn 47, Issue 4, 2012, Pages 463-469

  Aoyama, N ^a   Suzuki, J I ^a,b   Ogawa, M ^a,b   Watanabe, R ^a,b   Kobayashi, N ^a   Hanatani, T ^a   Yoshida, A ^a   Ashigaki, N ^a   Izumi, Y ^a   Isobe, M ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Aneurysm; Clarithromycin; Matrix metalloproteinase; Periodontal pathogen

Indexed keywords

ANTIINFECTIVE AGENT; CLARITHROMYCIN; DOXYCYCLINE; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE INHIBITOR; PROTEIN SYNTHESIS INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ABDOMINAL AORTA ANEURYSM; ANIMAL; ARTICLE; BLOOD; C57BL MOUSE; MALE; MICROBIOLOGY; MOUSE; PATHOLOGY; PORPHYROMONAS GINGIVALIS;

ANIMALS; ANTI-BACTERIAL AGENTS; AORTIC ANEURYSM, ABDOMINAL; CLARITHROMYCIN; DOXYCYCLINE; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASE INHIBITORS; MICE; MICE, INBRED C57BL; PORPHYROMONAS GINGIVALIS; PROTEIN SYNTHESIS INHIBITORS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 84862867860     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2011.01454.x     Document Type: Article

References (52)

1. Ernst CB. Abdominal aortic aneurysm. N Engl J Med 1993;328:1167-1172.
2. Alcorn HG, Wolfson SK Jr, Sutton-Tyrrell K, Kuller LH, O'Leary D. Risk factors for abdominal aortic aneurysms in older adults enrolled in The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1996;16:963-970.
3. Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 2002;110:625-632.
4. Freestone T, Turner RJ, Coady A, Higman DJ, Greenhalgh RM, Powell JT. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 1995;15:1145-1151.
5. Davis V, Persidskaia R, Baca-Regen L et al. Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 1998;18:1625-1633.
6. Choi BK, Jung JH, Suh HY et al. Activation of matrix metalloproteinase-2 by a novel oral spirochetal species Treponema lecithinolyticum. J Periodontol 2001;72:1594-1600.
7. Salvi GE, Lang NP. Host response modulation in the management of periodontal diseases. J Clin Periodontol 2005;32(suppl 6):108-129.
8. Ashley RA. Clinical trials of a matrix metalloproteinase inhibitor in human periodontal disease. SDD Clinical Research Team. Ann N Y Acad Sci 1999;878:335-346.
9. Moreillon P, Que YA. Infective endocarditis. Lancet 2004;363:139-149.
10. Li X, Kolltveit KM, Tronstad L, Olsen I. Systemic diseases caused by oral infection. Clin Microbiol Rev 2000;13:547-558.
11. Friedewald VE, Kornman KS, Beck JD et al. The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: periodontitis and atherosclerotic cardiovascular disease. Am J Cardiol 2009;104:59-68.
12. Andriankaja OM, Genco RJ, Dorn J et al. Periodontal disease and risk of myocardial infarction: the role of gender and smoking. Eur J Epidemiol 2007;22:699-705.
13. Bahekar AA, Singh S, Saha S, Molnar J, Arora R. The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta-analysis. Am Heart J 2007;154:830-837.
14. Cairo F, Castellani S, Gori AM et al. Severe periodontitis in young adults is associated with sub-clinical atherosclerosis. J Clin Periodontol 2008;35:465-472.
15. Herzberg MC, Weyer MW. Dental plaque, platelets, and cardiovascular diseases. Ann Periodontol 1998;3:151-160.
16. Seymour RA, Lowry R, Whitworth JM, Martin MV. Infective endocarditis, dentistry and antibiotic prophylaxis; time for a rethink? Br Dent J 2000;189:610-616.
17. Kurihara N, Inoue Y, Iwai T, Umeda M, Huang Y, Ishikawa I. Detection and localization of periodontopathic bacteria in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2004;28:553-558.
18. Suzuki J, Aoyama N, Ogawa M et al. Periodontitis and cardiovascular diseases. Expert Opin Ther Targets 2010;14:1023-1027.
19. Aoyama N, Suzuki J, Wang D et al. Porphyromonas gingivalis promotes murine abdominal aortic aneurysms via matrix metalloproteinase-2 induction. J Periodontal Res 2011;46:176-183.
20. Kikuchi T, Hagiwara K, Honda Y et al. Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-kappa B transcription factors. J Antimicrob Chemother 2002;49:745-755.
21. Abe S, Nakamura H, Inoue S et al. Interleukin-8 gene repression by clarithromycin is mediated by the activator protein-1 binding site in human bronchial epithelial cells. Am J Respir Cell Mol Biol 2000;22:51-60.
22. Ogawa M, Suzuki J, Hishikari K, Takayama K, Tanaka H, Isobe M. Clarithromycin attenuates acute and chronic rejection via matrix metalloproteinase suppression in murine cardiac transplantation. J Am Coll Cardiol 2008;51:1977-1985.
23. Hishikari K, Watanabe R, Ogawa M et al. Early treatment with clarithromycin attenuates rat autoimmune myocarditis via inhibition of matrix metalloproteinase activity. Heart 2010;96:523-527.
24. Genco CA, Arko RJ. Animal chamber models for study of host-parasite interactions. Methods Enzymol 1994;235:120-140.
25. Houri-Haddad Y, Itzchaki O, Ben-Nathan D, Shapira L. The effect of chronic emotional stress on the humoral immune response to Porphyromonas gingivalis in mice. J Periodontal Res 2003;38:204-209.
26. Kojima T, Yano K, Ishikawa I. Relationship between serum antibody levels and subgingival colonization of Porphyromonas gingivalis in patients with various types of periodontitis. J Periodontol 1997;68:618-625.
27. Manning MW, Cassis LA, Daugherty A. Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2003;23:483-488.
28. Chung AW, Yang HH, Radomski MW, van Breemen C. Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9. Circ Res 2008;102:e73-e85.
29. Pyo R, Lee JK, Shipley JM et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest 2000;105:1641-1649.
30. Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S. Periodontal disease and cardiovascular disease. J Periodontol 1996;67:1123-1137.
31. Chiu B. Multiple infections in carotid atherosclerotic plaques. Am Heart J 1999;138:S534-S536.
32. Dorn BR, Dunn WA Jr, Progulske-Fox A. Invasion of human coronary artery cells by periodontal pathogens. Infect Immun 1999;67:5792-5798.
33. Tonetti MS, D'Aiuto F, Nibali L et al. Treatment of periodontitis and endothelial function. N Engl J Med 2007;356:911-920.
34. Ramseier CA, Kinney JS, Herr AE et al. Identification of pathogen and host-response markers correlated with periodontal disease. J Periodontol 2009;80:436-446.
35. Soder PO, Meurman JH, Jogestrand T, Nowak J, Soder B. Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in blood as markers for early atherosclerosis in subjects with chronic periodontitis. J Periodontal Res 2009;44:452-458.
36. Grayson R, Douglas CW, Heath J, Rawlinson A, Evans GS. Activation of human matrix metalloproteinase 2 by gingival crevicular fluid and Porphyromonas gingivalis. J Clin Periodontol 2003;30:542-550.
37. Cotti E, Dessi C, Piras A, Mercuro G. Can a chronic dental infection be considered a cause of cardiovascular disease? A review of the literature Int J Cardiol 2010;148:4-10.
38. Ogawa M, Suzuki J, Takayama K, Isobe M. Matrix metalloproteinase suppression induced by clarithromycin in murine cardiac allografts. Transplant Proc 2009;41:395-397.
39. Baxter BT, Terrin MC, Dalman RL. Medical management of small abdominal aortic aneurysms. Circulation 2008;117:1883-1889.
40. Petrinec D, Liao S, Holmes DR, Reilly JM, Parks WC, Thompson RW. Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. J Vasc Surg 1996;23:336-346.
41. Prall AK, Longo GM, Mayhan WG et al. Doxycycline in patients with abdominal aortic aneurysms and in mice: comparison of serum levels and effect on aneurysm growth in mice. J Vasc Surg 2002;35:923-929.
42. Curci JA, Mao D, Bohner DG et al. Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms. J Vasc Surg 2000;31:325-342.
43. Baxter BT, Pearce WH, Waltke EA et al. Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study. J Vasc Surg 2002;36:1-12.
44. Inoue K, Kumakura S, Uchida M, Tsutsui T. Effect of eight antibacterial agents on cell survival and expression of epithelial-cell- or cell-adhesion-related genes in human gingival epithelial cells. J Periodont Res 2004;39:50-58.
45. Kudoh S, Azuma A, Yamamoto M, Izumi T, Ando M. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med 1998;157:1829-1832.
46. Sinisalo J, Mattila K, Valtonen V et al. Effect of 3months of antimicrobial treatment with clarithromycin in acute non-q-wave coronary syndrome. Circulation 2002;105:1555-1560.
47. Paju S, Pussinen PJ, Sinisalo J et al. Clarithromycin reduces recurrent cardiovascular events in subjects without periodontitis. Atherosclerosis 2006;188:412-419.
48. Paakkanen R, Palikhe A, Seppanen M et al. Beneficial effect of clarithromycin in patients with acute coronary syndrome and complement C4 deficiencies. Scand Cardiovasc J 2009;43:395-401.
49. Maimon N, Lipton JH, Chan CKN, Marras TK. Macrolides in the treatment of bronchiolitis obliterans in allograft recipients. Bone Marrow Transplant 2009;44:69-73.
50. Ianaro A, Ialenti A, Maffia P et al. Anti-inflammatory activity of macrilide antibiotics. J Pharmacol Exp Ther 2000;292:156-163.
51. Culic O, Erakovic V, Parnham MJ. Anti-inflammatory effects of macrolide antibiotics. Eur J Pharmacol 2001;429:209-229.
52. Arenas IA, Xu Y, Lopez-Jaramillo P, Davidge ST. Angiotensin II-induced MMP-2 release from endothelial cells is mediated by TNF-alpha. Am J Physiol Cell Physiol 2004;286:C779-C784.